Advanced Proteome Therapeutics Corporation Grants Stock Options
March 10 2009 - 3:38PM
Marketwired
Advanced Proteome Therapeutics Corporation (the "Company") (TSX
VENTURE: APC) announces that, pursuant to the Company's stock
option plan, it has granted incentive stock options to an officer
of the Company to purchase up to 300,000 common shares in the
capital of the Company, exercisable on or before March 10, 2014 at
a price of $0.27 per share. The option grant is subject to board
approval and the vesting provisions contained in the Company's
stock option plan.
About APC
APC's primary corporate mission is to apply its proprietary drug
delivery and drug redevelopment technologies to produce new,
improved versions of therapeutic proteins and pioneer the emerging
field of protein-site targeting. The market for diagnostics and
therapeutic proteins and peptides is expected to surpass more than
50 Billion USD by the year 2010 and is the fastest growing segment
of the pharmaceutical market. Future growth however depends largely
on the industry overcoming a number of hurdles, including drug
delivery challenges and the need for homogeneous conjugates that
APC is attempting to address.
ON BEHALF OF THE BOARD
Alexander (Allen) Krantz, President and Chief Executive
Officer
The TSX Venture Exchange does not accept responsibility for the
adequacy or accuracy of this release.
Contacts: Encompass Communications Inc. (604) 630-0770 or Toll
Free: 1-877-566-6592
Advanced Proteome Therap... (TSXV:APC)
Historical Stock Chart
From Dec 2024 to Jan 2025
Advanced Proteome Therap... (TSXV:APC)
Historical Stock Chart
From Jan 2024 to Jan 2025